Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane: A multicentric feasibility studyRASPAGLIESI, Francesco; ZANABONI, Flavia; SCIBILIA, Giuseppe et al.Oncology. 2004, Vol 67, Num 5-6, pp 376-381, issn 0030-2414, 6 p.Article

CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumoursFRAGGETTA, Filippo; PELOSI, Giuseppe; CAFICI, Alessia et al.Virchows Archiv. 2003, Vol 443, Num 6, pp 782-786, issn 0945-6317, 5 p.Article

Serotonin and Dopamine Play Complementary Roles in Gambling to Recover LossesCAMPBELL-MEIKLEJOHN, Daniel; WAKELEY, Judi; HERBERT, Vanessa et al.Neuropsychopharmacology (New York, NY). 2011, Vol 36, Num 2, pp 402-410, issn 0893-133X, 9 p.Article

Molecular profiling of human oocytes after vitrification strongly suggests that they are biologically comparable with freshly isolated gametesDI PIETRO, Cinzia; VENTO, Marilena; RITA GAROFALO, Maria et al.Fertility and sterility. 2010, Vol 94, Num 7, pp 2804-2807, issn 0015-0282, 4 p.Article

Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III TrialPIGNATA, Sandro; SCAMBIA, Giovanni; VERNAGLIA LOMBARDI, Alessandra et al.Journal of clinical oncology. 2011, Vol 29, Num 27, pp 3628-3635, issn 0732-183X, 8 p.Article

Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized studyBOLIS, Giorgio; SCARFONE, Giovanna; RASPAGLIESI, Francesco et al.European journal of cancer (1990). 2010, Vol 46, Num 16, pp 2905-2912, issn 0959-8049, 8 p.Article